Since then, ETV6-NTRK3 fusions have been identified in numerous other cancer types, including secretory breast carcinoma [14], acute myeloid leukemia [15], radiation-associated thyroid cancer [16], pediatric high-grade glioma [17], Philadelphia chromosome-like ALL, and other tumor types (Table 1). This evidence concerns the gene NTRK3 and neoplasm.